2026 NPPES data Gynecologic Oncology Physician NPI 1598847972 MD
Verify on CMS →

Pedro Ramirez, MD

Gynecologic Oncology Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,364 in Gynecologic Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
44
Medicare Part D claims · 16 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.4K
12 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Pedro Ramirez, MD filed 44 Medicare Part D claims in 2023 as a Gynecologic Oncology Physician in Houston, Texas, prescribing 57% generic.

44
Part D claims, 2023
57%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Pedro Ramirez, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

44 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Pedro Ramirez, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Pedro Ramirez, MD?

Quality data not reported

NPI registry status

Active

Issued 10/19/2006

NPI 1598847972

Primary specialty

Gynecologic Oncology Physician

Niche

1,364 US NPIs in this specialty

Medicare Part D claims

44 77% vs specialty avg

2023 prescription claims

Specialty avg: 188

Specialty distribution in Texas

How Gynecologic Oncology Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Gynecologic Oncology Physician - 0%Gynecologic Oncology Physician0%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Gynecologic Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Pedro Ramirez, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 1515 HOLCOMBE BLVD, Houston, TX, 77030, with a listed phone of (713) 792-6161. NPI 1598847972 was issued on 10/19/2006.

Medicare Part D records for calendar year 2023 show 44 prescription claims written by this provider, covering 16 Medicare beneficiaries and totaling roughly $219K in drug spend, split 43% brand-name and 57% generic by claim count.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,364 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1515 HOLCOMBE BLVD
Houston, TX 77030

Provider Details

NPI 1598847972
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Male
NPI Issued 10/19/2006

Hospital and facility affiliations

Facilities where Pedro Ramirez, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Houston Methodist Specialty Physicians
Houston, TX
Tmh Physician Associates PLLC
Houston, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Pedro Ramirez, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.4K

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Pedro Ramirez, MD. To verify Pedro Ramirez, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Pedro Ramirez, MD - brand share 43.0%
Gynecologic Oncology Physician average

43% brand-name claims vs 57% generic, on 44 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

44
Total Claims
$219K
Total Drug Cost
16
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
61
Total Day Supply
1,551
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$218K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
74.8 years
Avg HCC Risk Score
3.01
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Lynparza
Olaparib
15
Letrozole
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How Pedro Ramirez, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,364
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

Pedro Ramirez, MD's 44 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Ramirez.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Gynecologic Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Pedro Ramirez, MD's specialty?
Pedro Ramirez, MD specializes in Gynecologic Oncology Physician and practices in Houston, Texas. Credentials: MD.
How much does Pedro Ramirez, MD prescribe under Medicare Part D?
In 2023, Pedro Ramirez, MD wrote 44 Medicare Part D claims totaling $219K in drug costs for 16 beneficiaries.
Where is Pedro Ramirez, MD located?
Pedro Ramirez, MD is located at 1515 HOLCOMBE BLVD, Houston, TX, 77030. Phone: (713) 792-6161.
What is Pedro Ramirez, MD's NPI number?
Pedro Ramirez, MD's National Provider Identifier (NPI) is 1598847972, issued on 10/19/2006.
Does Pedro Ramirez, MD prescribe more brand-name or generic drugs?
Pedro Ramirez, MD's prescribing is 43% brand-name and 57% generic drugs by claim count, with $218K in brand drug costs.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,364 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does Pedro Ramirez, MD prescribe most often?
Based on 2023 Medicare Part D data, Pedro Ramirez, MD's most frequently prescribed drugs include Lynparza, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Pedro Ramirez, MD accept Medicare?
Pedro Ramirez, MD appears in CMS Medicare data with 44 Part D claims and 16 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Pedro Ramirez, MD's credentials?
Pedro Ramirez, MD's NPI is 1598847972 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.